NRC Health
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Trent Green
- Full Time Employees
- 357
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 1245 Q Street Lincoln NE United States of America 68508
- IPO Date
- May 23, 2013
- CIK
- 0000070487
- Website
- nrchealth.com
- Similar Companies
- Business
- National Research Corporation (NRC) operates as a healthcare insights and analytics company specializing in healthcare experience management solutions designed to enhance patient, employee, physician, and consumer engagement. Its core offerings include multi-channel feedback collection and analysis platforms; patient and family experience measurement; resident and family experience programs for long-term care; employee and physician engagement solutions; healthcare analytics encompassing market and clinical outcomes analysis; health risk assessments; patient outreach initiatives; and integrated healthcare experience management solutions. NRC delivers these services primarily to healthcare providers, hospitals, and long-term care facilities across the United States with a strong emphasis on human-centered conversational listening enhanced by next-generation artificial intelligence technologies. Founded in 1981 and headquartered in Lincoln, Nebraska, NRC has recently focused on transformative growth by integrating advanced AI capabilities into its product suite to deliver more adaptive and personalized healthcare experience management tools. In 2024–2025, the company intensified investments in AI-enhanced healthcare-specific solutions set for market rollout, expanded its sales force, and pursued strategic initiatives to deepen customer engagement and market penetration. NRC also returned $18 million to shareholders through dividends and stock repurchases during the first quarter of 2024, signaling robust financial stewardship. The company's strategic roadmap includes leveraging AI and broadening its healthcare experience platform to better serve evolving client needs in a competitive market. NRC continues to reinforce its position as a leader in healthcare experience analytics by advancing innovative solutions that address regulatory compliance, patient satisfaction, and operational performance improvements. NRC operates exclusively in the healthcare industry with offerings tailored to hospitals, healthcare systems, long-term care providers, and related healthcare organizations across North America. The company maintains a comprehensive portfolio of market insights, consumer assessment programs (including CMS-approved surveys), clinical analytics, and consulting services. Its recent operational enhancements and AI focus position NRC at the forefront of delivering actionable data-driven insights that help healthcare organizations optimize patient outcomes, satisfaction, and loyalty while navigating regulatory and market pressures effectively.
Company News
New Momentum in the Nuclear Fuel Chain
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
Mercy Earns National Honor for Excellence in Patient Experience
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
Financial Review: National Research (NASDAQ:NRC) versus Lynx Global Digital Finance (OTCMKTS:CNONF)
Terrestrial Energy Reports Second Quarter 2026 Results
NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth
NRC Health (NRC) Q2 2026 Earnings Call Transcript
National Research Q2 Earnings Call Highlights
NRC Health Announces Second Quarter 2026 Results
Nations Royalty Reports Fiscal 2026 Year-End Results and Provides Portfolio Update
90,182 Shares in National Research Corporation $NRC Bought by Fifth Third Bancorp
Terra Innovatum Initiates NRC Preapplication Readiness Review to Support Solo™ Construction Permit Application
Constellation Seeks License Renewals for Two New York Units Through 2049
NANO Nuclear's KRONOS MMR™ Program Advances as U.S. NRC Initiates Formal Review Activities with University of Illinois Urbana-Champaign and NANO Nuclear Energy
NANO Nuclear's KRONOS MMR(TM) Program Advances as U.S. NRC Initiates Formal Review Activities with University of Illinois Urbana-Champaign and NANO Nuclear Energy
AtkinsRéalis submits Notice of Intent to U.S. Nuclear Regulatory Commission for CANDU® reactor licensing
RZOLV Technologies Completes NRC IRAP-Supported R&D Project for Non-Cyanide Gold Extraction Technology
Nuclear Regulatory Commission Issues Positive Decision for enCore Energy's Dewey Burdock Uranium Project
Georgia's Plant Hatch receives 20-year license renewal from the Nuclear Regulatory Commission